Amidine derived inhibitors of acid-sensing ion channel-3 (ASIC3).
A series of indole amidines modified at the 2-position of the indole ring were evaluated as inhibitors of Acid-Sensing Ion Channel-3 (ASIC3), a novel target for the treatment of chronic pain.